Nuvalent
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(857) 357-7000Website
www.nuvalent.comRevenue
-Stock Symbol
NUVLIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Nuvalent
Nuvalent is a biotechnology company focused on developing precision therapies for non-small-cell lung cancer. Its two lead programs both target cancer genes using enzyme blockers known as kinase inhibitors, with the goal of minimizing a patient's resistance to cancer treatments. The company was founded in 2017 and is headquartered out of Cambridge, MA.Explore more
Nuvalent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvalent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nuvalent recently announced quarterly report
Product Launch: Get notified when Nuvalent launches new products
Funding: Get notified immidiatlly once Nuvalent has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nuvalent
Check out if Nuvalent is spiking on competitors!
Nuvalent, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nuvalent had a recent Job posting/layoffs
Check if Nuvalent has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nuvalent
Compare insights from companies similar to Nuvalent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvalent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvalent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvalent.
Nuvalent financials insights
Gather financial insights about Nuvalent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Multiple Rounds
$351M
Nuvalent Tech Stack
A closer look at the technologies used by Nuvalent
See more technologies
Most Recent Scoops
Person-Based
Pharmaceuticals
Project
Nuvalent is planning to submit TKI-naive data to the FDA in the second half of the year to support a line extension into TKI-naive ROS1.
Pharmaceuticals
Project
Nuvalent has received Priority Review from the FDA for neladalkib, with a PDUFA date in November of this year, following the Phase II ALKOVE-1 study, which enrolled approximately 800 patients in roughly 13 months, and the company reports it is on track to have the confirmatory Phase III trial substantially enrolled by year-end as required for accelerated approval.
Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Nuvalent News & Media
GSK completes acquisition of Nuvalent, Inc.
GSK plc today announced completion of its acquisition of Nuvalent, Inc. , a Boston-based clinical-stage biopharmaceutical company.BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSE - TMHC),
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.GSK announces commencement of tender offer to acquire Nuvalent, Inc.
GSK plc today announced that Harmony Row Acquisition Co. has commenced a tender offer to purchase all of the shares of Nuvalent, Inc.Here’s What the Acquisition of Nuvalent Means for Nuvation Bio (NUVB)
Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Penny Stocks That Could Skyrocket in 2026. On June 9, Reuters reported that GSK agreed to acquire cancer drug developer Nuvalent for a deal worth $10.6 billion. On the same day, RBC Capital reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a price target […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuvalent
Sign Up For FreeTo access detailed company insights
Nuvalent is a biotechnology company focused on developing precision therapies for non-small-cell lung cancer. Its two lead programs both target cancer genes using enzyme blockers known as kinase inhibitors, with the goal of minimizing a patient's resistance to cancer treatments. The company was founded in 2017 and is headquartered out of Cambridge,... Read More
